Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.60 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 7/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.49 |
| ▸ | HTR2A | P28223 | 3/20 | 0.43 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2202797 | 0.82 | SLC6A2 (0.54) | ARSLC6A4SLC6A2SLC6A3 | |
| SCHEMBL4163791 | 0.80 | AR (0.64) | ARSLC6A4SLC6A2SLC6A3HTR2A | |
| SCHEMBL20510911 | 0.76 | AR (0.44) | ARSMN1; SMN2POLBGAA | |
| SCHEMBL4101870 | 0.76 | AR (0.44) | ARSMN1; SMN2POLBGAA | |
| SCHEMBL4171623 | 0.76 | AR (1.00) | AR | |
| SCHEMBL3632404 | 0.75 | TSHR (0.46) | ARALDH1A1SMN1; SMN2GAA | |
| SCHEMBL20510966 | 0.75 | AR (0.60) | ARSLC6A4HTR2AALDH1A1POLB | |
| SCHEMBL18164415 | 0.74 | SLC6A4 (0.49) | ARSLC6A4SLC6A2SLC6A3HTR2A | |
| SCHEMBL17060529 | 0.74 | AR (0.46) | ARSLC6A4SLC6A2SLC6A3KCNH2 | |
| SCHEMBL3071329 | 0.73 | ALDH1A1 (0.50) | ARSLC6A4SLC6A2SLC6A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11648545-B2 | Transition metal-based heterogeneous carbonylation reaction catalyst and method for preparing lactone or succinic anhydride using catalyst | KOOKMIN UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION (KR) | 2023-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11648545-B2 | Transition metal-based heterogeneous carbonylation reaction catalyst and method for preparing lactone or succinic anhydride using catalyst | OGDH, CA12, COASY | AR 1791/4885SLC6A4 4660/4885SLC6A2 4857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.